Access our latest presentations including a webcast of our presentation at the Bank of America Merrill Lynch Global Healthcare Conference 2014 on September 19 as well as scientific posters and presentations in our Download Library.
Genmab's CEO shares his perspective on how the company's work to develop innovative antibody therapeutics could change the lives of cancer patients in the future. Click here to watch the video.
Genmab is inviting researchers in academia and industry to experience the full power of the DuoBody® platform for bispecific antibody research and drug development. Explore the possibilities via our recently published Perspective in the journal mAbs and the renewed Open Innovation section on DuoBody.com.